Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Hypertrophic cardiomyopathy (HCM) is a genetic disease characterized by the hypertrophy (thickening) of heart ventricles, and the first cause of sudden cardiac death in the young adults. The ECG is altered in the majority of patients with HCM as a consequence of structural and electrophysiological abnormalities although reliable risk markers are still not available. Fifty four 12-lead Holter recordings (32 HCM patients and 22 controls) have been analyzed in order to obtain specific ECG based biomarkers able to distinguish between both groups. Results showed higher values for HCM in QRS-duration, QT interval (QTc), T peak to T end interval corrected (T pe ) and DRest quantifying dispersion of restitution. Also, morphological features such as ST level, T and QRS amplitudes and energies and the first four Karhunen-Loeve transform (KLT) coefficients were analysed. Results showed statistically significant differences between HCM patients and controls (p-value < 0.02) in the QTc interval, ST level, energies and the first and third KLT coefficients. DRest showed higher values in HCM patients (0.08 versus 0.05 in controls) in agreement with in vivo studies suggesting a correlation between increased dispersion and arrhythmic risk.

Type

Conference paper

Publication Date

01/01/2014

Volume

41

Pages

397 - 400